Research | OneLook Acronym Finder |
Serial Number | 79340793 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2022-02-25 | Application Filed |
2022-05-19 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2022-05-19 | Status: Live/Pending |
2022-05-20 | Transaction Date |
Owner: | Bicycletx Limited |
Entity Statement | Limited Company |
Address | Building 900, GB |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease |
GS0051 | Pharmaceuticals, namely, preparations and products for use in the treatment and prevention of disease in the field of oncology for both solid and liquid tumours, for use in the treatment and prevention of metabolic disease, urology and renal disease, in the cardiovascular field, in the field of hematology, for use in the treatment and prevention of respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of oncology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of ophthalmology; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging, namely, clinical imaging agents; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-05-19 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-05-20 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-05-24 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-09-07 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-09-10 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-09-11 | 6 RFCR E:E-Mail |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2022-09-24 | 7 ADCH M: |
REFUSAL PROCESSED BY MPU | 2022-10-28 | 8 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-10-28 | 9 RFCS P: |
REFUSAL PROCESSED BY IB | 2022-11-21 | 10 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-04-20 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-04-20 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-04-21 | 13 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-05-22 | 14 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-06-07 | 15 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-06-07 | 16 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-06-07 | 17 OPNS P: |
NOTIFICATION PROCESSED BY IB | 2023-06-25 | 18 GPNX P: |
PUBLISHED FOR OPPOSITION | 2023-06-27 | 19 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-06-27 | 20 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2023-09-12 | 21 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-09-12 | 22 NRCC E:E-Mail |
NEW REPRESENTATIVE AT IB RECEIVED | 2023-12-01 | 23 NREP P: |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-12-12 | 24 FICR P: |
FINAL DISPOSITION PROCESSED | 2023-12-14 | 25 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2023-12-14 | 26 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2024-01-08 | 27 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.